Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study

Documenti analoghi

• Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis
  di: Alessandro Mantovani, et al.
  Pubblicazione: (2024)
• Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis
  di: Mohamad Jamalinia, et al.
  Pubblicazione: (2025)
• Qualitative Properties of Circulating Fatty Acids Are Associated With MASLD : A Cross‐Sectional Study From the NHANES Database
  di: Stefano Ciardullo, et al.
  Pubblicazione: (2025)
• PNPLA3 variation and kidney disease
  di: Alessandro Mantovani, et al.
  Pubblicazione: (2024)
• Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
  di: Claudio Maffeis, et al.
  Pubblicazione: (2024)